CPO
FLGT icon

Cerity Partners OCIO’s Fulgent Genetics FLGT Stock Holding History

Cerity Partners OCIO’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15,829
Closed -$1.42M – 424
2021
Q3 		$1.42M Buy
15,829
+4,569
+41% +$415K 0.05% 164
2021
Q2 		$1.04M Buy
11,260
+1,903
+20% +$152K 0.03% 198
2021
Q1 		$904K Sell
9,357
-424
-4% -$43.8K 0.03% 193
2020
Q4 		$510K Buy
+9,781
New +$409K 0.02% 254

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Cerity Partners OCIO's FLGT Position: Q4 2021 in Review

Cerity Partners OCIO sold out of Fulgent Genetics (FLGT) in Q4 2021, closing a stake of 15,829 shares — an estimated $1.42M sold.

Cerity Partners OCIO first reported a position in FLGT in Q4 2020 and held it in 4 quarters. The position peaked at $1.42M in Q3 2021. 299 funds tracked by Wall St. Rank hold FLGT as of Q4 2021.

  • Cerity Partners OCIO reported no remaining Fulgent Genetics position as of Q4 2021 after selling out during the quarter.
  • Cerity Partners OCIO sold 15,829 Fulgent Genetics shares in Q4 2021, an estimated $1.42M.
  • Cerity Partners OCIO first reported a position in Fulgent Genetics in Q4 2020 and held it in 4 quarters.
  • Cerity Partners OCIO's Fulgent Genetics position peaked at $1.42M in Q3 2021.
  • 299 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2021.

Based on Cerity Partners OCIO's 13F filing for Q4 2021, filed 28 Jan 2022.